TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
PCVX

Vaxcyte Inc

Healthcare · Biotechnology

56.20$ -1.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PCVX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – –
– +165,820.0% +18.8% +14.0% +146.0% +173.4% +7.6% +55.8% +56.9%
– +191,951.3% +58.2% +358.6% +97.4% +120.4% +106.2% +74.0% +63.7%
– – – – +106.8% +153.1% – – –
– +189,400.0% +106.2% +802.5% -204.9% – +538.5% -167.5% –
– +145,071.8% -32.6% -3.3% +467.5% -10.9% +1,062.1% -67.0% -38.9%
– +158,771.0% -32.6% -7.5% +19,113.4% – -1,136.8% +159.4% –
– – – – – – – – –
– +41.8% -31.3% -99.1% +137.4% +16.3% +97.3% – –
– +50.5% -1.8% -78.1% -100.0% – – – –
– +141,695.3% -33.2% +801.8% -95.3% +4,741.2% -25.7% +282.7% -99.9%
– +107,715.0% -123.8% – -196.7% – -157.1% – –
– – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?